Breaking News Instant updates and real-time market news.

2019-10-23 05:28:43 LNG Cheniere Energy $63.88 0.15 (0.24%) 05:28 10/23/19 10/23 05:28 10/23/19 05:28	Cheniere Energy upgraded to Outperform from Market Perform at Raymond James Raymond James analyst Justin Jenkins upgraded Cheniere Energy to Outperform from Market Perform with a $71 price target.	01 Nov
LNG Cheniere Energy $63.88 0.15 (0.24%) 05/13/19 GABE 05/13/19 INITIATION GABE Sell Cheniere Energy Partners initiated with a Sell at Gabelli Gabelli analyst Matthew Trusz initiated coverage of the liquefied natural gas, or LNG, market, stating that demand will significantly exceed current supply by 2025, led by Chinese growth. Cheniere Energy (LNG), the only public pure-play LNG developer with operating liquefaction facilities, is undervalued, but Cheniere Energy Partners (CQP) is overvalued, said Trusz, who started the former at Buy and the latter at Sell. The partnership has limited opportunity for expansion and incremental EBITDA will "flow disproportionately to its general partner," Trusz tells investors in his initiation note. 07/16/19 BTIG 07/16/19 INITIATION BTIG Neutral Cheniere Energy initiated with a Neutral at BTIG BTIG initiated Cheniere Energy with a Neutral rating, saying that while the firm's "bullish LNG thesis remains intact," BTIG believes Cheniere is "already pricing in a recovery in Asian LNG prices," and is fairly valued. 09/20/19 MSCO 09/20/19 INITIATION Target $74 MSCO Equal Weight Cheniere Energy assumed with an Equal Weight at Morgan Stanley Morgan Stanley analyst Devin McDermott assumed coverage of Cheniere Energy with an Equal Weight rating and $74 price target. He believes the current stock price reflects close to fair value for the company's contracted cash flows from Sabine Pass and Corpus Christi. 10/21/19 RBCM 10/21/19 INITIATION Target $84 RBCM Outperform Cheniere Energy initiated with an Outperform at RBC Capital RBC Capital analyst Elvira Scotto initiated coverage of Cheniere Energy with an Outperform rating and $84 price target. The analyst is positive on the company's cash flow visibility thanks to its long-term contracts with "high credit quality" counterparties. Scotto also cites Cheniere's first-mover advantage amid a more competitive environment given its "proven" execution track record, strong relationships, and a cost-of-capital advantage that allow for flexibility with financing and structuring contracts.

2019-10-23 05:28:43

LNG

Cheniere Energy

$63.88: 0.15 (0.24%)

05:28

10/23/19

10/23

05:28

10/23/19

05:28

Cheniere Energy upgraded to Outperform from Market Perform at Raymond James

Raymond James analyst Justin Jenkins upgraded Cheniere Energy to Outperform from Market Perform with a $71 price target.

01
Nov

LNG Cheniere Energy

$63.88: 0.15 (0.24%)

05/13/19: GABE

07/16/19: BTIG

09/20/19: MSCO

10/21/19: RBCM

TODAY'S FREE FLY STORIES

PAYS Paysign $11.27 -0.56 (-4.73%) 20:32 11/14/19 11/14 20:32 11/14/19 20:32 Initiation	Paysign initiated at DA Davidson » Paysign initiated with a… Paysign initiated with a Buy at DA Davidson. DA Davidson analyst Peter Heckmann initiated coverage of Paysign with a Buy rating and $16 price target. The analyst says the company has generated an "impressive" growth over the past 5 years and expects its top-line trends to remain strong. Heckmann further notes that Paysign should see margin expansion from 2019 to 2021 and believes that the recent pullback in the stock price presents a buying opportunity. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Nov 25 Nov 26 Nov
LPTX Leap Therapeutics $0.57 -0.5922 (-50.83%) 20:25 11/14/19 11/14 20:25 11/14/19 20:25 Downgrade	Leap Therapeutics rating change at Raymond James » Leap Therapeutics… Leap Therapeutics downgraded to Market Perform from Outperform at Raymond James. Raymond James downgraded Leap Therapeutics to Market Perform from Outperform. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FTNT Fortinet $100.07 0.38 (0.38%) 20:25 11/14/19 11/14 20:25 11/14/19 20:25 Upgrade	Fortinet rating change at Credit Suisse » Fortinet upgraded to… Fortinet upgraded to Neutral from Underperform at Credit Suisse. Credit Suisse upgraded Fortinet to Neutral from Underperform. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov 18 Nov 19 Nov 05 Dec 06 Dec 09 Dec 12 Dec
JD JD.com $33.57 0.21 (0.63%) , WVE Wave Life Sciences $27.90 -0.07 (-0.25%) … 20:25 11/14/19 11/14 20:25 11/14/19 20:25 Earnings	Notable companies reporting before tomorrow's open » Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include JD.com (JD), consensus 17c... Wave Life Sciences (WVE), consensus ($1.44)... Rhythm Pharmaceuticals (RYTM), consensus (88c)... JCPenney (JCP), consensus (56c). JD JD.com $33.57 0.21 (0.63%) WVE Wave Life Sciences $27.90 -0.07 (-0.25%) RYTM Rhythm Pharmaceuticals $21.52 0.38 (1.80%) JCP J.C. Penney $1.10 0.01 (0.92%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov 15 Nov 09 Dec
SBS Sabesp $12.21 -0.02 (-0.16%) 20:22 11/14/19 11/14 20:22 11/14/19 20:22 Earnings	Sabesp reports Q3 adjusted EBITDA up 109.8% at BRL3.01B » Reports Q3 adjusted… Reports Q3 adjusted EBITDA margin 55.6% vs. 37.6% last year. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Nov

LINX Linx S.A. $7.11 -0.8 (-10.11%) 19:16 11/14/19 11/14 19:16 11/14/19 19:16 Recommendations	Linx S.A. analyst commentary at Jefferies » Linx S.A. price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov
CNP CenterPoint Energy $26.68 -1.42 (-5.05%) 19:12 11/14/19 11/14 19:12 11/14/19 19:12 Downgrade	CenterPoint Energy rating change at Credit Suisse » CenterPoint Energy… CenterPoint Energy downgraded to Neutral from Outperform at Credit Suisse. Credit Suisse analyst Michael Weinstein downgraded CenterPoint Energy to Neutral from Outperform with a $28 price target. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $309.54 0.46 (0.15%) 19:09 11/14/19 11/14 19:09 11/14/19 19:09 Periodicals	Kudlow says U.S. near trade agreement with China, Reuters says » White House economic… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $309.54 0.46 (0.15%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BMRN BioMarin $75.55 -0.54 (-0.71%) 18:41 11/14/19 11/14 18:41 11/14/19 18:41 Hot Stocks	BioMarin CEO: Our products have a very long life cycle » In an interview on… In an interview on CNBC's Mad Money, BioMarin CEO Jean-Jacques Bienaime said: Confident in reaching $2B in revenue next year. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec
OXY Occidental Petroleum $37.76 -0.36 (-0.94%) 18:38 11/14/19 11/14 18:38 11/14/19 18:38 Periodicals	Judge rejects Icahn's suit seeking Occidental acquisition records, Reuters says » A Delaware court judge… A Delaware court judge determined that activist investor Carl Icahn will not have access to Occidental Petroleum's Anadarko takeover records to support his proxy battle against the company's board, Reuters reports. In his ruling, Vice Chancellor Joseph Slights said that Icahn's complaint against the oil firm "appear to be nothing more than disagreements" with its directors and failed to show how the documents would move his proxy contest forward, the report says. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

FTCH Farfetch $7.49 -0.54 (-6.72%) , DGII Digi International $15.10 0.33 (2.23%) … 18:35 11/14/19 11/14 18:35 11/14/19 18:35 Hot Stocks	Fly Intel: After Hours Movers » UP AFTER EARNINGS:… UP AFTER EARNINGS: Farfetch (FTCH) up 19.0%... Digi International (DGII) up 12.6%... Applied Materials (AMAT) up 3.8%... Kulicke and Soffa (KLIC) up 2.3%... Helmerich & Payne (HP) up 2.3%... Wheaton Precious Metals (WPM) up 2.0%. ALSO HIGHER: Radnet (RDNT) up 9.6% after entering S&P SmallCap 600 index... RH (RH) up 7.0% after Berkshire Hathaway disclosed new stake in company. DOWN AFTER EARNINGS: Aurora Cannabis (ACB) down 11.6%... Osmotica (OSMT) down 9.2%... Globant (GLOB) down 4.8%... Dolby Labs (DLB) down 3.8%... Nvidia (NVDA) down 1.4%. Movers as of 18:15ET. FTCH Farfetch $7.49 -0.54 (-6.72%) DGII Digi International $15.10 0.33 (2.23%) AMAT Applied Materials $56.89 -0.24 (-0.42%) KLIC Kulicke & Soffa $25.18 -0.22 (-0.87%) HP Helmerich & Payne $39.30 0.04 (0.10%) WPM Wheaton Precious Metals $26.47 -0.12 (-0.45%) RDNT RadNet $15.92 0.09 (0.57%) RH RH $175.19 1.98 (1.14%) ACB Aurora Cannabis $3.29 -0.25 (-7.06%) OSMT Osmotica Pharmaceuticals $4.00 -0.03 (-0.74%) GLOB Globant $108.99 3.975 (3.79%) DLB Dolby $65.56 -0.14 (-0.21%) NVDA Nvidia $209.88 1.33 (0.64%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 14 Nov 14 Nov 14 Nov 14 Nov 14 Nov 14 Nov 14 Nov 15 Nov 15 Nov 15 Nov 20 Nov 03 Dec 04 Dec 05 Dec 09 Dec 09 Dec 12 Dec 13 Dec 06 Jan
VIA Viacom $25.31 0.175 (0.70%) , VIAB Viacom $22.48 0.44 (2.00%) … 18:24 11/14/19 11/14 18:24 11/14/19 18:24 Hot Stocks	Viacom CEO: The road ahead for the company is very exciting » In an interview on… In an interview on CNBC's Mad Money, Viacom (VIA, VIAB) CEO Bob Bakish said: I'm really pleased with fourth quarter results... Merger with CBS (CBS) poised to close in early December... There are material synergies on both the cost and revenue side for this merger... We are playing all the segments and that is what makes us different... People who say we can't compete in streaming are absolutely wrong... The content market is very frothy. VIA Viacom $25.31 0.175 (0.70%) VIAB Viacom $22.48 0.44 (2.00%) CBS CBS $37.62 0.78 (2.12%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 14 Nov 09 Dec
NVDA Nvidia $209.88 1.33 (0.64%) 18:22 11/14/19 11/14 18:22 11/14/19 18:22 Hot Stocks	Breaking Hot Stocks news story on Nvidia » Nvidia CFO says continue… Nvidia CFO says continue to see 'great traction' in enterprise business 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 20 Nov 06 Jan
NVDA Nvidia $209.88 1.33 (0.64%) 18:04 11/14/19 11/14 18:04 11/14/19 18:04 Hot Stocks	Nvidia CEO says Q4 will be much stronger driven by AI and inference » Says computational… Says computational intensity is "so high" that, aside from computer graphics, only accelerators make the work loads possible. Comments taken from Q3 earnings conference call Q/A. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 20 Nov 06 Jan
BABA Alibaba $182.69 0.21 (0.12%) 17:50 11/14/19 11/14 17:50 11/14/19 17:50 Syndicate	Alibaba launches Hong Kong IPO » Alibaba Group Holding… Alibaba Group Holding Limited (BABA) announced the launch of its Hong Kong public offering, which forms part of the global offering of 500M new ordinary shares and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 9988. The company's American depositary shares, or ADSs, each representing eight ordinary shares of the company, will continue to be listed and traded on the New York Stock Exchange. Upon listing in Hong Kong, the Hong Kong-listed shares will be fully fungible with the ADSs listed on the NYSE. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Nov

17:49 11/14/19 11/14 17:49 11/14/19 17:49 Conference/Events	William Blair SaaS analyst to hold a luncheon meeting » SaaS Analyst Pfau holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
HP Helmerich & Payne $39.30 0.04 (0.10%) 17:49 11/14/19 11/14 17:49 11/14/19 17:49 Earnings	Helmerich & Payne sees FY20 CapEx approximately $275M-$300M » 57-62% expected for… 57-62% expected for maintenance, 17-19% expected for tubular purchases, 11-15% for skidding to walking conversions, and roughly 10% for corporate and information technology projects. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov
PPG PPG $129.82 -0.5 (-0.38%) , PG Procter & Gamble $120.49 -0.15 (-0.12%) … 17:49 11/14/19 11/14 17:49 11/14/19 17:49 Hot Stocks	Trian Fund exits PPG, cuts Wendy's in Q3 » Nelson Peltz' Trian… PPG PPG $129.82 -0.5 (-0.38%) PG Procter & Gamble $120.49 -0.15 (-0.12%) MDLZ Mondelez $52.90 0.2 (0.38%) LM Legg Mason $38.60 -0.22 (-0.57%) GE General Electric $11.30 -0.01 (-0.09%) WEN Wendy's $20.90 -0.01 (-0.05%) BK BNY Mellon $48.42 0.07 (0.14%) SYY Sysco $81.51 0.27 (0.33%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 15 Nov 19 Nov 19 Nov 02 Dec 11 Dec 16 Jan 29 Jan
HP Helmerich & Payne $39.30 0.04 (0.10%) 17:48 11/14/19 11/14 17:48 11/14/19 17:48 Earnings	Helmerich & Payne reports Q4 cont ops EPS 38c, consensus 23c » Reports Q4 revenue… Reports Q4 revenue $649.05M, consensus $646.58M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov
17:47 11/14/19 11/14 17:47 11/14/19 17:47 Conference/Events	DA Davidson software analysts to hold a dinner meeting » Analysts host a Security… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

MDCO The Medicines Co. $50.89 -1.905 (-3.61%) 17:46 11/14/19 11/14 17:46 11/14/19 17:46 Conference/Events	Roth Capital pharmaceuticals analysts to hold a luncheon » Analysts host Dr. John… Analysts host Dr. John Kastelein, Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, who discusses Inclisiran's ORION Trials at a Luncheon Meeting being held in Philadelphia on November 16. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Nov
NVDA Nvidia $209.88 1.33 (0.64%) 17:44 11/14/19 11/14 17:44 11/14/19 17:44 Hot Stocks	Nvidia CFO says Q3 decline in automotive revenue driven by one-time item » Says AI cockbit business… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 20 Nov 06 Jan
CPE Callon Petroleum $4.20 -0.265 (-5.94%) , PSDO Presidio $16.56 -0.02 (-0.12%) … 17:44 11/14/19 11/14 17:44 11/14/19 17:44 Hot Stocks	Paulson adds Callon Petroleum, lowers stake in Lyft in Q3 » John Paulson's… John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of September 30, 2019. Paulson's four new buys during the third quarter included, by size of position, Callon Petroleum (CPE), Presidio (PSDO), and Overseas Shipholding Group (OSG). The firm exited nine positions during the quarter, including Stewart Information (STC). Paulson increased its stake in eight holdings, including by size of previous position Allergan (AGN), Horizon Therapeutics (HZNP), Spark Therapeutics (ONCE), Mylan (MYL), and Sprint (S). The firm reduced its stake in nine holdings, including by size of previous position Lyft (LYFT), T-Mobile (TMUS), PG&E (PCG), WellCare Health Plans (WCG), and Tim Participacoes (TSU). Paulson's top holdings as of September 30, in order of size, were SPDR Gold Shares (GLD), Allergan, Bausch Health (BHC), Celgene (CELG), and Discovery Class C (DISCK). CPE Callon Petroleum $4.20 -0.265 (-5.94%) PSDO Presidio $16.56 -0.02 (-0.12%) OSG Overseas Shipholding $1.84 0.045 (2.51%) STC Stewart $43.10 0.11 (0.26%) AGN Allergan $182.47 0.91 (0.50%) HZNP Horizon Pharma $29.82 -0.48 (-1.58%) ONCE Spark Therapeutics $110.78 -0.65 (-0.58%) MYL Mylan $17.26 -0.01 (-0.06%) S Sprint $5.86 -0.21 (-3.46%) LYFT Lyft $41.90 -1.39 (-3.21%) TMUS T-Mobile $76.87 -1.15 (-1.47%) PCG PG&E $6.70 -0.19 (-2.76%) WCG WellCare $301.86 -2.56 (-0.84%) TSU Tim Participacoes $15.53 0.44 (2.92%) GLD SPDR Gold Shares $138.57 0.59 (0.43%) BHC Bausch Health $27.77 0.38 (1.39%) CELG Celgene $110.03 -0.42 (-0.38%) DISCK Discovery Inc. $28.04 0.12 (0.43%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Nov 18 Nov 19 Nov 19 Nov 04 Dec 07 Dec 09 Dec 07 Jan 25 Mar 04 Apr
17:41 11/14/19 11/14 17:41 11/14/19 17:41 Conference/Events	BTIG energy analysts to hold a luncheon » Energy Analysts host… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
17:40 11/14/19 11/14 17:40 11/14/19 17:40 Conference/Events	Wolfe Research tech strategist to hold analyst/industry webcast » Tech Strategist… Tech Strategist Milunovich and Electrical Equipment & Multi-Industry Analyst Coe, along with Ian Hughes, Analyst for Internet of Things at 451 Research, discuss the outlook for Internet of Things (IoT) on an Analyst/Industry webcast to be held on November 18 at 11 am.

Events

Earnings calls, analyst events, roadshows and more

JD
Today at 07:00

JD.com - JD Conference Calls
VAR
Today at 08:00

Varian Medical Systems Firm Sponsored Meetings

The Plaza Hotel Fifth Avenue at Central Park South, New York, NY
SLS
Today at 08:15

SELLAS Life Sciences Group, Inc. Firm Sponsored Meetings

, New York, NY
Today at 08:30

Export Prices Y/Y: October 2019 Government Event
Today at 08:30

Retail Sales Control Group M/M: October 2019 Government Event
Today at 08:30

Empire State Mfg Survey--General Business Conditions Index: November 2019 Government Event
Today at 08:30

Import Prices M/M: October 2019 Government Event
Today at 08:30

Retail Sales M/M: October 2019 Government Event
Today at 08:30

Export Prices M/M: October 2019 Government Event
Today at 08:30

Retail Sales less Autos M/M: October 2019 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ETNB X ETNB 89bio IPO Managers: BofA/Merrill, SVB Leerink & RBC Capital, Oppenheimer Priced at: $16.00 5.305M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	YAYO X YAYO YayYo IPO Managers: Aegis & Westpark Priced at: $4.00 2.65M Shares CDAY X CDAY Ceridian Spot Secondary Managers: JPMorgan Priced at: $53.40 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CWK X CWK Cushman & Wakefield Spot Secondary Managers: Morgan Stanley Priced at: $18.35 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RNG X RNG RingCentral Spot Secondary Managers: Goldman Sachs & BofA/Merrill Priced at: $169.00 1.75M Shares
Wed	BCRX X BCRX BioCryst Secondary Managers: JPMorgan, JMP Securities, H.C. Wainwright Priced at: $1.45 37.93M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LPCN X LPCN Lipocine Secondary Managers: Roth Capital Priced at: $.50 10.45M Shares REPL X REPL Replimune Group Secondary Managers: JPMorgan, SVB Leerink & BMO Capital Priced at: $13.61 3.678M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RETA X RETA Reata Pharmaceuticals Secondary Managers: Citi, Jefferies, SVB Leerink & Stifel Priced at: $183.00 2.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FLGT X FLGT Fulgent Genetics Spot Secondary Managers: Piper Jaffray Priced at: $11.25 2.325M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KDMN X KDMN Kadmon Spot Secondary Managers: Jefferies & Cantor Fitzgerald, H.C. Wainwright, Oppenheimer Priced at: $3.40 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRRM X VRRM Verra Mobility Spot Secondary Managers: Morgan Stanley Priced at: $14.25 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	LNT X LNT Alliant Energy Spot Secondary Managers: Barclays Priced at: $52.63 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	PHIO X PHIO Phio Pharmaceuticals Spot Secondary Managers: H.C. Wainwright $0.27
Thurs	FND X FND Floor & Decor Block Trade Managers: Morgan Stanley $43.95-44.25 7.1M Shares NXTC X NXTC NextCure Secondary Managers: Morgan Stanley, BofA/Merrill & Piper Jaffray, Needham, BTIG $37.41 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PRPL X PRPL Purple Innovation Secondary Managers: BofA/Merrill & Oppenheimer, Raymond James, KeyBanc $8.91 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWAV X SWAV ShockWave Medical Secondary Managers: Morgan Stanley & BofA/Merrill $36.72 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Cheniere Energy upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Get Full Fly Access